Sabby Management as of Sept. 30, 2018
Portfolio Holdings for Sabby Management
Sabby Management holds 124 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr option | 15.0 | $117k | 4.0k | 29.07 | |
| Spdr S&p 500 Etf Tr option | 14.9 | $116k | 4.0k | 29.07 | |
| Ishares Tr Index option | 8.6 | $67k | 4.0k | 16.86 | |
| Biogen Idec Inc option | 7.9 | $62k | 1.7k | 35.33 | |
| Ishares Tr option | 4.6 | $36k | 2.1k | 16.85 | |
| Esperion Therapeutics Inc Ne | 3.8 | $30k | 6.7k | 4.44 | |
| Nektar Therapeutics Cmn Stk cmn | 3.6 | $29k | 4.7k | 6.10 | |
| Sarepta Therapeutics Inc. cmn | 3.6 | $28k | 1.7k | 16.15 | |
| Spdr S&p Oil & Gas Exp & Pr call | 2.3 | $18k | 1.9k | 9.59 | |
| Nektar Therapeutics (NKTR) | 2.3 | $18k | 295k | 0.06 | |
| Amarin Corp Plc option | 2.0 | $16k | 9.8k | 1.63 | |
| Tilray Inc put | 1.9 | $15k | 1.1k | 14.36 | |
| Astrazeneca Plc option | 1.9 | $15k | 3.8k | 3.96 | |
| Sarepta Therapeutics Inc. cmn | 1.9 | $15k | 908.00 | 16.15 | |
| ASTRAZENECA Plc-spons | 1.8 | $14k | 3.6k | 3.96 | |
| Zogenix Inc call | 1.7 | $13k | 2.6k | 4.96 | |
| Biogen Idec (BIIB) | 1.6 | $13k | 36k | 0.35 | |
| Zosano Pharma Corp | 1.6 | $12k | 251k | 0.05 | |
| Odonate Therapeutics Ord | 1.3 | $10k | 524k | 0.02 | |
| Fibrogen | 1.1 | $8.8k | 1.4k | 6.07 | |
| Xeris Pharmaceuticals | 1.1 | $8.6k | 487k | 0.02 | |
| Viking Therapeutics Inc put | 0.9 | $6.7k | 3.9k | 1.74 | |
| Fibrogen | 0.7 | $5.6k | 916.00 | 6.08 | |
| Unum Therapeutics Ord | 0.7 | $5.6k | 541k | 0.01 | |
| Sangamo Biosciences Inc Cmn Stk cmn | 0.7 | $5.3k | 3.1k | 1.70 | |
| Spdr S&p Oil & Gas Exp & Pr put | 0.7 | $5.2k | 540.00 | 9.59 | |
| Global Blood Therapeutics In call | 0.6 | $5.0k | 1.3k | 3.80 | |
| Esperion Therapeutics (ESPR) | 0.6 | $4.5k | 100k | 0.04 | |
| Aveo Pharmaceuticals | 0.5 | $4.0k | 12k | 0.33 | |
| Oramed Pharm (ORMP) | 0.5 | $3.8k | 801k | 0.00 | |
| Ophthotech | 0.5 | $3.9k | 1.6M | 0.00 | |
| Nektar Therapeutics | 0.5 | $3.6k | 592.00 | 6.10 | |
| Brainstorm Cell Therapeutics (BCLI) | 0.4 | $3.4k | 907k | 0.00 | |
| Vascular Biogenics | 0.4 | $3.4k | 2.1M | 0.00 | |
| Oncobiologics | 0.4 | $3.4k | 3.4M | 0.00 | |
| Madrigal Pharmaceuticals | 0.4 | $3.3k | 154.00 | 21.42 | |
| Amicus Therapeutics | 0.4 | $2.8k | 2.4k | 1.21 | |
| Viking Therapeutics (VKTX) | 0.4 | $2.8k | 164k | 0.02 | |
| Sangamo Biosciences (SGMO) | 0.3 | $2.7k | 157k | 0.02 | |
| Alkermes Plc cmn | 0.3 | $2.4k | 571.00 | 4.24 | |
| Amicus Therapeutics Inc option | 0.3 | $2.0k | 1.7k | 1.21 | |
| Amicus Therapeutics (FOLD) | 0.2 | $1.9k | 155k | 0.01 | |
| Soleno Therapeutics | 0.2 | $1.7k | 755k | 0.00 | |
| Genprex | 0.2 | $1.7k | 733k | 0.00 | |
| Marinus Pharmaceuticals Inc call | 0.2 | $1.6k | 1.6k | 1.00 | |
| Adverum Biotechnologies Inc call | 0.2 | $1.3k | 2.2k | 0.60 | |
| Mannkind Corp put | 0.2 | $1.3k | 7.2k | 0.18 | |
| Cytrx Corp | 0.2 | $1.3k | 1.3M | 0.00 | |
| Arcadia Biosciences | 0.2 | $1.4k | 277k | 0.00 | |
| Aptinyx | 0.1 | $1.2k | 41k | 0.03 | |
| Magenta Therapeutics | 0.1 | $1.1k | 94k | 0.01 | |
| IsoRay | 0.1 | $962.743500 | 1.9M | 0.00 | |
| Medigus | 0.1 | $1.0k | 297k | 0.00 | |
| Synergy Pharmaceuticals Del | 0.1 | $914.940000 | 5.4k | 0.17 | |
| Viking Therapeutics Inc call | 0.1 | $941.004000 | 540.00 | 1.74 | |
| Monaker Group | 0.1 | $978.058400 | 445k | 0.00 | |
| Pavmed Inc *w exp 04/30/202 (PAVMZ) | 0.1 | $973.419000 | 1.9M | 0.00 | |
| Medigus Ltd *w exp 07/23/202 | 0.1 | $887.702200 | 1.3M | 0.00 | |
| Amarin Corp Plc option | 0.1 | $827.990300 | 509.00 | 1.63 | |
| Insmed | 0.1 | $832.981600 | 412.00 | 2.02 | |
| Ricebran Technologies | 0.1 | $815.076900 | 281k | 0.00 | |
| Opiant Pharmaceuticals | 0.1 | $782.874400 | 44k | 0.02 | |
| Atossa Genetics (ATOS) | 0.1 | $837.070200 | 465k | 0.00 | |
| Eidos Therapeutics | 0.1 | $767.400000 | 77k | 0.01 | |
| Fibrogen (FGEN) | 0.1 | $729.553300 | 12k | 0.06 | |
| Novan | 0.1 | $702.682400 | 251k | 0.00 | |
| Senestech | 0.1 | $685.091400 | 979k | 0.00 | |
| Galmed Pharmaceuticals | 0.1 | $600.249600 | 44k | 0.01 | |
| Eyenovia Inc equity (EYEN) | 0.1 | $653.428000 | 163k | 0.00 | |
| Aldeyra Therapeutics | 0.1 | $589.003800 | 427.00 | 1.38 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $556.368000 | 278k | 0.00 | |
| Superconductor Technologies | 0.1 | $518.306400 | 288k | 0.00 | |
| Proteostasis Therapeutics In | 0.1 | $479.760000 | 200k | 0.00 | |
| Sophiris Bio Inc put | 0.1 | $439.946400 | 1.6k | 0.28 | |
| Neurometrix | 0.1 | $484.786900 | 373k | 0.00 | |
| Chf Solutions | 0.1 | $507.861600 | 423k | 0.00 | |
| Bio Path Holdings | 0.1 | $388.350800 | 971k | 0.00 | |
| Fuelcell Energy Inc put | 0.1 | $372.012000 | 3.5k | 0.11 | |
| Cellect Biotechnology Ltd spon ads | 0.1 | $415.281600 | 87k | 0.00 | |
| Check Cap Ord | 0.1 | $363.084000 | 91k | 0.00 | |
| Biocept Inc Com Par | 0.1 | $398.767600 | 142k | 0.00 | |
| Sesen Bio Inc put | 0.1 | $391.945000 | 1.8k | 0.21 | |
| Microbot Med (MBOT) | 0.1 | $403.433200 | 55k | 0.01 | |
| Insmed (INSM) | 0.0 | $303.000000 | 15k | 0.02 | |
| Ophthotech | 0.0 | $286.968600 | 1.2k | 0.24 | |
| Axovant Sciences | 0.0 | $324.652800 | 135k | 0.00 | |
| Titan Pharmaceutical | 0.0 | $303.658800 | 1.5M | 0.00 | |
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $321.000000 | 1.5k | 0.21 | |
| Conatus Pharmaceuticals | 0.0 | $253.023000 | 437.00 | 0.58 | |
| Dbv Technologies S A call | 0.0 | $261.000000 | 116.00 | 2.25 | |
| Hemispherx Biopharma | 0.0 | $228.726400 | 1.1M | 0.00 | |
| Inspiremd | 0.0 | $214.200800 | 1.1M | 0.00 | |
| Check Cap | 0.0 | $245.502400 | 307k | 0.00 | |
| DURECT Corporation | 0.0 | $145.090000 | 132k | 0.00 | |
| Ovascience | 0.0 | $179.062100 | 256k | 0.00 | |
| Applied Dna Sciences Inc *w exp 11/21/201 | 0.0 | $123.208600 | 616k | 0.00 | |
| Sunesis Pharmaceuticals Inc call | 0.0 | $191.000000 | 955.00 | 0.20 | |
| Ritter Pharmaceuticals | 0.0 | $190.000000 | 100k | 0.00 | |
| Trovagene | 0.0 | $122.910400 | 154k | 0.00 | |
| Pluristem Therapeutics Inc. cmn | 0.0 | $40.996800 | 312.00 | 0.13 | |
| Durect | 0.0 | $68.970000 | 627.00 | 0.11 | |
| Scynexis | 0.0 | $49.894800 | 42k | 0.00 | |
| Kitov Pharmaceuticals Hldgs | 0.0 | $45.973100 | 27k | 0.00 | |
| Adverum Biotechnologies Inc put | 0.0 | $101.992800 | 168.00 | 0.61 | |
| Onconova Therapeutics Inc *w exp 07/07/202 | 0.0 | $66.547000 | 666k | 0.00 | |
| Sigma Labs Inc *w exp 02/15/202 | 0.0 | $84.158700 | 281k | 0.00 | |
| Cel Sci (CVM) | 0.0 | $101.745600 | 25k | 0.00 | |
| Yield10 Bioscience | 0.0 | $66.836000 | 48k | 0.00 | |
| Sellas Life Sciences Group I | 0.0 | $93.952800 | 78k | 0.00 | |
| Rxi Pharmaceuticals Corp *w | 0.0 | $78.103600 | 195k | 0.00 | |
| Stellar Biotechnologies | 0.0 | $65.602600 | 47k | 0.00 | |
| Aytu Bioscience | 0.0 | $99.304800 | 36k | 0.00 | |
| Ophthotech | 0.0 | $31.002300 | 133.00 | 0.23 | |
| Cormedix Inc put | 0.0 | $28.011200 | 287.00 | 0.10 | |
| Benitec Biopharma Ltd *w exp 08/14/202 | 0.0 | $5.805000 | 58k | 0.00 | |
| Cesca Therapeutics | 0.0 | $5.996400 | 20k | 0.00 | |
| Cytori Therapeuti 18 Wts equities | 0.0 | $0 | 38k | 0.00 | |
| Inspiremd Inc *w | 0.0 | $0 | 499k | 0.00 | |
| Inspiremd Inc *w exp 03/14/202 | 0.0 | $0 | 1.8M | 0.00 | |
| Citius Pharmaceuticals (CTXR) | 0.0 | $19.658800 | 12k | 0.00 | |
| Opgen | 0.0 | $33.916000 | 17k | 0.00 | |
| Reshape Lifesciences Ord | 0.0 | $0 | 462k | 0.00 | |
| Helios & Matheson Analytics call | 0.0 | $0 | 125.00 | 0.00 | |
| Electrameccanica Vehs Corp *w exp 08/03/202 | 0.0 | $40.400000 | 101k | 0.00 |
